Jiangsu Hualan New Pharmaceutical Material Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
April 24, 2022 at 04:49 am EDT
Share
Jiangsu Hualan New Pharmaceutical Material Co., Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was CNY 819.27 million compared to CNY 443.65 million a year ago. Revenue was CNY 820.87 million compared to CNY 446.32 million a year ago. Net income was CNY 216.02 million compared to CNY 81.36 million a year ago. Basic earnings per share from continuing operations was CNY 2.026 compared to CNY 0.806 a year ago. Diluted earnings per share from continuing operations was CNY 2.026 compared to CNY 0.806 a year ago.
Jiangsu Hualan New Pharmaceutical Material Co Ltd is a China-based company primarily engaged in the research, development, production and sales of packaging materials for direct contact injection drugs. The Companyâs main products include various kinds of coated rubber stoppers, conventional rubber stoppers and others. The Company's products are mainly used in the field of pharmaceutical preparations such as infusion, freeze-drying, powder injection, monoclonal antibodies, small water injections, blood sampling, and Chinese medicine compound preparations, among others. The Company also produces plastic infusion container assemblies and urinary anorectal minimally invasive surgical instruments. The Company distributes its products within the domestic market and to overseas markets, including Italy, Egypt, Saudi Arabia, Qatar and other areas.
JIANGSU HUALAN NEW PHARMACEUTICAL MATERIAL CO.,LTD. 
